Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Margaret L. Van Keuren is active.

Publication


Featured researches published by Margaret L. Van Keuren.


Nature | 2003

Loss of Omi mitochondrial protease activity causes the neuromuscular disorder of mnd2 mutant mice

Julie M. Jones; Pinaki Datta; Srinivasa M. Srinivasula; Weizhen Ji; Sanjeev Gupta; Zhi Jia Zhang; Erika Davies; György Hajnóczky; Thomas L. Saunders; Margaret L. Van Keuren; Teresa Fernandes-Alnemri; Miriam H. Meisler; Emad S. Alnemri

The mouse mutant mnd2 (motor neuron degeneration 2) exhibits muscle wasting, neurodegeneration, involution of the spleen and thymus, and death by 40 days of age. Degeneration of striatal neurons, with astrogliosis and microglia activation, begins at around 3 weeks of age, and other neurons are affected at later stages. Here we have identified the mnd2 mutation as the missense mutation Ser276Cys in the protease domain of the nuclear-encoded mitochondrial serine protease Omi (also known as HtrA2 or Prss25). Protease activity of Omi is greatly reduced in tissues of mnd2 mice but is restored in mice rescued by a bacterial artificial chromosome transgene containing the wild-type Omi gene. Deletion of the PDZ domain partially restores protease activity to the inactive recombinant Omi protein carrying the Ser276Cys mutation, suggesting that the mutation impairs substrate access or binding to the active site pocket. Loss of Omi protease activity increases the susceptibility of mitochondria to induction of the permeability transition, and increases the sensitivity of mouse embryonic fibroblasts to stress-induced cell death. The neurodegeneration and juvenile lethality in mnd2 mice result from this defect in mitochondrial Omi protease.


Transgenic Research | 2009

Generating transgenic mice from bacterial artificial chromosomes: transgenesis efficiency, integration and expression outcomes

Margaret L. Van Keuren; Galina B. Gavrilina; Wanda E. Filipiak; Michael G. Zeidler; Thomas L. Saunders

Transgenic mice are widely used in biomedical research to study gene expression, developmental biology, and gene therapy models. Bacterial artificial chromosome (BAC) transgenes direct gene expression at physiological levels with the same developmental timing and expression patterns as endogenous genes in transgenic animal models. We generated 707 transgenic founders from 86 BAC transgenes purified by three different methods. Transgenesis efficiency was the same for all BAC DNA purification methods. Polyamine microinjection buffer was essential for successful integration of intact BAC transgenes. There was no correlation between BAC size and transgenic rate, birth rate, or transgenic efficiency. A narrow DNA concentration range generated the best transgenic efficiency. High DNA concentrations reduced birth rates while very low concentrations resulted in higher birth rates and lower transgenic efficiency. Founders with complete BAC integrations were observed in all 47 BACs for which multiple markers were tested. Additional founders with BAC fragment integrations were observed for 65% of these BACs. Expression data was available for 79 BAC transgenes and expression was observed in transgenic founders from 63 BACs (80%). Consistent and reproducible success in BAC transgenesis required the combination of careful DNA purification, the use of polyamine buffer, and sensitive genotyping assays.


Mammalian Genome | 2007

Genetic variation in C57BL/6 ES cell lines and genetic instability in the Bruce4 C57BL/6 ES cell line

Elizabeth D. Hughes; Yun Yan Qu; Suzanne J. Genik; Robert H. Lyons; Christopher D. Pacheco; Andrew P. Lieberman; Linda C. Samuelson; Igor O. Nasonkin; Sally A. Camper; Margaret L. Van Keuren; Thomas L. Saunders

Genetically modified mouse strains derived from embryonic stem (ES) cells are powerful tools for gene function analysis. ES cells from the C57BL/6 mouse strain are not widely used to generate mouse models despite the advantage of a defined genetic background. We assessed genetic variation in six such ES cell lines with 275 SSLP markers. Compared to C57BL/6, Bruce4 differed at 34 SSLP markers and had significant heterozygosity on three chromosomes. BL/6#3 and Dale1 ES cell lines differed at only 3 SSLP makers. The C2 and WB6d ES cell lines differed at 6 SSLP markers. It is important to compare the efficiency of producing mouse models with available C57BL/6 ES cells relative to standard 129 mouse strain ES cells. We assessed genetic stability (the tendency of cells to become aneuploid) in 110 gene-targeted ES cell clones from the most widely used C57BL/6 ES cell line, Bruce4, and 710 targeted 129 ES cell clones. Bruce4 clones were more likely to be aneuploid and unsuitable for ES cell-mouse chimera production. Despite their tendency to aneuploidy and consequent inefficiency, use of Bruce4 ES cells can be valuable for models requiring behavioral studies and other mouse models that benefit from a defined C57BL/6 background.


Transgenic Research | 2004

Rederivation of Transgenic and Gene-Targeted Mice by Embryo Transfer

Margaret L. Van Keuren; Thomas L. Saunders

Research on genetically engineered mice provides insights into the etiology, therapy, and genetic basis of human diseases. An important variable that affects the results of mouse studies is the health status of the animals. Pathogen burdens may confound observations and obscure underlying mechanisms. Mouse resource centers frequently rederive infected mouse strains. We review our experience on the use of a well-established technique, embryo transfer to rederive infected mouse strains. The following mouse pathogens were eliminated by embryo transfer: Mouse Parvovirus, Mouse Hepatitis Virus, Mouse Rotavirus, Mouse Encephalomyelitis Virus, Mouse Adenovirus, Helicobacter species, endoparasites, and ectoparasites. We rederived transgenic mouse lines, gene-targeted mouse lines, and lines with spontaneous mutations. In the majority of strains, fertilized eggs for embryo transfer were obtained by mating superovulated egg donors with males of the desired genotype. A total of 309 embryo transfers were performed to rederive 96 mouse strains. The pregnancy rate was 76%; 1996 pups were born, of which 43% carried the desired genotype. We performed 44 additional embryo transfers to rederive 15 other strains. The pregnancy rate was lower (45%) and none of the 135 pups carried the desired genotype. Although we successfully eliminated the pathogens in all transfers, we were unable to obtain pups with the desired genotype in 15 of 111 mouse lines. Multiple factors affect the efficiency of rederivation by embryo transfer. They include the response to superovulation by embryo donors, the number and age of stud males, the yield of fertilized eggs, the number of embryo transfers, and genotyping.


Human Genetics | 1988

Isolation of DNA sequences on human chromosome 21 by application of a recombination-based assay to DNA from flow-sorted chromosomes

Umadevi Tantravahi; Gordon D. Stewart; Margaret L. Van Keuren; Gerard McNeil; Sayon Roy; David Patterson; Harry A. Drabkin; Marc Lalande; David M. Kurnit; Samuel A. Latt

SummaryBy merging two efficient technologies, bivariate flow sorting of human metaphase chromosomes and a recombination-based assay for sequence complexity, we isolated 28 cloned DNA segments homologous to loci on human chromosome 21. Subregional mapping of these DNA segments with a somatic cell hybrid panel showed that 26 of the 28 cloned DNA sequences are distributed along the long arm of chromosome 21, while the other 2 hybridize with sequences on the short arm of both chromosome 21 and other chromosomes. This new collection of probes homologous to chromosome 21 should facilitate molecular analyses of trisomy 21 by providing DNA probes for the linkage map of chromosome 21, for studies of nondisjunction, for chromosome walking in clinically relevant subregions of chromosome 21, and for the isolation of genes on chromosome 21 following the screening of cDNA libraries.


PLOS Genetics | 2013

A Novel Intergenic ETnII-β Insertion Mutation Causes Multiple Malformations in Polypodia Mice

Jessica Lehoczky; Peedikayil E. Thomas; Kevin M. Patrie; Kailey M. Owens; Lisa M. Villarreal; Kenneth Galbraith; Joe Washburn; Craig N. Johnson; Bryant J. Gavino; Alexander D. Borowsky; Kathleen J. Millen; Paul Wakenight; William D. Law; Margaret L. Van Keuren; Galina B. Gavrilina; Elizabeth D. Hughes; Thomas L. Saunders; Lesil E Brihn; Joseph H. Nadeau; Jeffrey W. Innis

Mouse early transposon insertions are responsible for ∼10% of spontaneous mutant phenotypes. We previously reported the phenotypes and genetic mapping of Polypodia, (Ppd), a spontaneous, X-linked dominant mutation with profound effects on body plan morphogenesis. Our new data shows that mutant mice are not born in expected Mendelian ratios secondary to loss after E9.5. In addition, we refined the Ppd genetic interval and discovered a novel ETnII-β early transposon insertion between the genes for Dusp9 and Pnck. The ETn inserted 1.6 kb downstream and antisense to Dusp9 and does not disrupt polyadenylation or splicing of either gene. Knock-in mice engineered to carry the ETn display Ppd characteristic ectopic caudal limb phenotypes, showing that the ETn insertion is the Ppd molecular lesion. Early transposons are actively expressed in the early blastocyst. To explore the consequences of the ETn on the genomic landscape at an early stage of development, we compared interval gene expression between wild-type and mutant ES cells. Mutant ES cell expression analysis revealed marked upregulation of Dusp9 mRNA and protein expression. Evaluation of the 5′ LTR CpG methylation state in adult mice revealed no correlation with the occurrence or severity of Ppd phenotypes at birth. Thus, the broad range of phenotypes observed in this mutant is secondary to a novel intergenic ETn insertion whose effects include dysregulation of nearby interval gene expression at early stages of development.


Genomics | 1996

Isolation of Human and Murine Homologues of the Drosophila Minibrain Gene: Human Homologue Maps to 21q22.2 in the Down Syndrome “Critical Region”

Woo Joo Song; Lawrence R. Sternberg; Carol Kasten-Sportès; Margaret L. Van Keuren; Sul Hee Chung; Alison C. Slack; Diane E. Miller; Thomas W. Glover; Pei Wen Chiang; Liandi Lou; David M. Kurnit


Genomics | 1996

Identification and analysis of the human and murine putative chromatin structure regulator SUPT6H and Supt6h

Pei Wen Chiang; Su Qing Wang; Paul Smithivas; Woo Joo Song; Saravanan Ramamoorthy; Joseph Hillman; Sheryl Puett; Margaret L. Van Keuren; Eric Crombez; Arun Kumar; Thomas W. Glover; Diane E. Miller; Chun Hui Tsai; C. Clare Blackburn; Xiao Ning Chen; Zhiguang Sun; Jan Fang Cheng; Julie R. Korenberg; David M. Kurnit


Toxicology and Applied Pharmacology | 2004

Resistance to organophosphorus agent toxicity in transgenic mice expressing the G117H mutant of human butyrylcholinesterase.

Yuxia Wang; Andreea Ticu Boeck; Ellen G. Duysen; Margaret L. Van Keuren; Thomas L. Saunders; Oksana Lockridge


Teratology | 1993

Expression of the IV (reversed and/or heterotaxic) phenotype in SWV mice

W. M. Layton; M. W. Layton; Michael Binder; David M. Kurnit; Andrzej J. Hanzlik; Margaret L. Van Keuren; Fred G. Biddle

Collaboration


Dive into the Margaret L. Van Keuren's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge